PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.\', \'Advanced Clinical Biosystems Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.\', \'F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.\', \'Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, USA.\', \'F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. jonathan.braun2@cshs.org.\', \'Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. jonathan.braun2@cshs.org.\', \'Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. susan.cheng@cshs.org.\', \'Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. kimia.sobhani@cshs.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41591-021-01325-6
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 33795870
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
?:title
  • Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all